DrugPatentWatch Database Preview

Investigational Drug Information for L-Alanine

Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug L-Alanine?

L-Alanine is an investigational drug.

There have been 10 clinical trials for L-Alanine. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1^st 2013.

The most common disease conditions in clinical trials are Myocardial Ischemia, Syndrome, and Coronary Disease. The leading clinical trial sponsors are National Cancer Institute (NCI), Emmaus Medical, Inc., and Oregon Research Institute.

There are one hundred and forty US patents protecting this investigational drug and two international patents.

Summary for L-Alanine

US Patents	140
International Patents	2,297
US Patent Applications	257
WIPO Patent Applications	1
Japanese Patent Applications	0
Clinical Trial Progress	Phase 3 (2013-11-01)
Vendors	96

Recent Clinical Trials for L-Alanine

Title	Sponsor	Phase
Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19	National Cancer Institute (NCI)	Phase 2
Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19	University of Southern California	Phase 2
18F-DOPA-PET/MRI Scan in Imaging Elderly Patients With Newly Diagnosed Grade IV Malignant Glioma or Glioblastoma During Planning for a Short Course of Proton Beam Radiation Therapy	National Cancer Institute (NCI)	Phase 2

See all L-Alanine clinical trials

Clinical Trial Summary for L-Alanine

Top disease conditions for L-Alanine

Top clinical trial sponsors for L-Alanine

See all L-Alanine clinical trials

US Patents for L-Alanine

Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
L-Alanine		Synthetic polymeric drugs	Ceskoslovenska Akademie Ved (Praha, CS) Carlton Medical Products Limited (London, GB2)
L-Alanine		Substituted amino acid compounds	Adir et Compagnie (Courbevoie, FR)
L-Alanine		Solid phase peptide synthesis using a polyacrylic support in aqueous solution	Societe d'Expansion Scientifque Expansia (FR)
L-Alanine		Cyclic anticoagulant peptides	Merrell Dow Pharmaceuticals Inc. (Cincinnati, OH)
L-Alanine		Amino nitrile intermediate for the preparation of alanine diacetic acid	The Dow Chemical Company (Midland, MI)

International Patents for L-Alanine

Drugname	Country	Document Number	Estimated Expiration	Related US Patent
L-Alanine	Austria	AT60991	2005-01-04
L-Alanine	Australia	AU5183386	2005-01-04
L-Alanine	Australia	AU589587	2005-01-04
L-Alanine	Canada	CA1305053	2005-01-04
L-Alanine	Germany	DE3581921	2005-01-04